bpc 157 human clinical trial injection site near injury evidence Musculoskeletal and Tissue Healing with 157: Weight Loss and Vitality: Medical Weight Loss bpc-157 safety evidence human clinical

186 Its main biological effects are selective inhibition of PDE4, leading to increased cAMP levels in inflammatory cells, regulating the activity of inflammatory cells and regulating the release of inflammatory factors to exhibit anti-inflammatory effects

This Full EUA Prescribing Information may have been updated

By preventing nicotinamide methylation, the compound increases intracellular NAD+ availability, which in turn activates sirtuins and other NAD+-dependent enzymes critical for metabolic homeostasis

### AOD-9604 Mechanism of Action AOD-9604 is believed to promote **fat loss** through: - Stimulation of lipolysis in adipose tissue via beta-3 adrenergic receptor pathways - Inhibition of lipogenesis (new fat formation) - No effect on growth hormone receptors (does not promote tissue growth) - No effect on IGF-1 levels or blood glucose Importantly, AOD-9604 does **not** suppress appetite or affect food intake it is purely a lipolytic **fat loss peptide**

Mechanism of Action AOD-9604s mechanism has been researched and the molecules part in the stimulation of nitric oxide synthase and in fat metabolic processes are being reviewed